Regulation of the growth hormone-insulin-like growth factor I axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor I

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 6, 1998, Pages 2018-2028

  Wilson, M E ^a  

^a EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; GROWTH HORMONE; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; ESTROGEN THERAPY; FEMALE; GROWTH HORMONE RELEASE; HORMONAL REGULATION; NONHUMAN; PRIORITY JOURNAL; PUBERTY; RHESUS MONKEY;

AGING; ANIMALS; ESTRADIOL; FEEDBACK; FEMALE; GROWTH HORMONE; GROWTH HORMONE-RELEASING HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MACACA MULATTA; OVARIECTOMY; SEXUAL MATURATION;

ANIMALIA; MACACA MULATTA;

EID: 0031732510     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.6.2018     Document Type: Article

References (76)

1. Mansfield MJ, Rudlin CR, Crigler JF, et al. 1988 Changes in growth and serum growth hormone and plasma somatomedin-C levels during suppression of gonadal sex steroid secretion in girls with central precocious puberty. J Clin Endocrinol Metab. 66:3-9.
2. Mauras N, Rogol AD, Veldhuis JD. 1989 Specific, time-dependent actions of low dose ethinyl estradiol administration on the episodic release of growth hormone, follicle stimulating hormone, and luteinizing hormone in prepubertal girls with Turner's syndrome. J Clin Endocrinol Metab. 69:1053-1058.
3. Argente J, Barrios V, Pozo J, et al. 1993 Normative data for insulin-like growth factors (IGFs), IGF-binding proteins, and growth hormone-binding protein in a healthy Spanish population: age-and sex-related changes. J Clin Endocrinol Metab. 77:1522-1528.
4. Juul A, Dalgaard P, Blum WF, et al. 1995 Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab. 80:2534-2542.
5. Liu F, Powell DR, Styne DM, Hintz RL. 1991 Insulin-like growth factors (IGFs) and IGF-binding proteins in the developing rhesus monkey. J Clin Endocrinol Metab. 72:905-911.
6. Corpas E, Harman SM, Blackman MR. 1993 Human growth hormone and human aging. Endocr Rev. 14:20-39.
7. Juul A, Main K, Blum WF, Lindholm J, Ranke MB, Skakkebaek NE. 1994 The ratio between serum levels of insulin-like growth factor (IGF)-I and IGF bonding proteins (IGFBP-1, 2, and 3) decreases with age in healthy adults and is increased in acromegalic patients. Clin Endocrinol (Oxf). 41:85-93.
8. Deslauriers N, Gaudreau P, Abribat T, Renier G, Petitclerc D, Brazeau P. 1991 Dynamics of growth hormone responsiveness to growth hormone releasing factor in aging rats: peripheral and central influences. Neuroendocrinology. 53:439-446.
9. Martinoli MG, Ouellet J, Rheaume E, Pelletier G. 1991 Growth hormone and somatostatin gene expression in adult and aging rats as measured by quantitative in situ hybridization. Neuroendocrinology. 54:607-615.
10. Wilshire GB, Loughlin JS, Brown JR, Adel TE, Santoro N. 1995 Diminished function of the somatotropic axis in older reproductive-aged women. J Clin Endocrinol Metab. 80:608-613.
11. Coiro V, Volpi R, Capretti L. 1996 Age-dependent decrease in growth hormone response to growth hormone releasing hormone in normally cycling women. Fertil Steril. 66:230-234.
12. Turner JP, Tannenbaum GS. 1995 In vivo evidence of a positive role for somatostatin to optimize pulsatile growth hormone secretion. Am J Physiol. 269:E683-E690.
13. Ho KY, Evans WS, Blizzard RM, et al. 1987 Effects of sex and age on 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab. 64:51-58.
14. Faria AC, Bekenstein LW, Booth RA, et al. 1992 Pulsatile growth hormone release in normal women during the menstrual cycle. Clin Endocrinol (Oxf). 36:591-596.
15. Gravholt CH, Naeraa RW, Fisker S, Christiansen JS. 1997 Body composition and physical fitness are major determinants of the growth hormone-insulin-like growth factor axis aberrations in adult Turner's syndrome, with important modulations by treatment with 17β-estradiol. J Clin Endocrinol Metab. 82:2570-2577.
16. Friend KE, Hartman ML, Pezzoli SS, Clasey JL, Thomer MO. 1996 Both oral and transdermal estrogen increse growth hormone release in post menopausal women-a clinical research center study. J Clin Endocrinol Metab. 81:2250-2256.
17. Weissberger ASJ, Ho KKY, Lazarus L. 1991 Contrasting effects of oral and trasdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor-I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab. 72:374-381.
18. Bellantoni MF, Vittone J, Campfield AT, Bass KM, Harman SM, Blackman MR 1996 Effects of oral. vs. transdermal estrogen on the growth hormone/ insulin-like growth-factor I axis in younger and older postmenopausal women: a clinical research center study. J Clin Endocrinol Metab. 81:2848-2853.
19. Eakman GD, Dallas JS, Ponder SW, Keenan BS. 1996 The effects of testosterone and dihydrotestosterone on hypothalamic regulation of growth hormone secretion. J Clin Endocrinol Metab. 81:1217-1223.
20. 3H]estradiol in GRF neurons. Endocrinology. 127:344-349.
21. Argente J, Chowen JA, Zeitler P, Clifton, Steiner RA. 1992 Sex steroid and developmental regulation of somatostatin and growth hormone-releasing hormone gene expression. In: Hernandez M, Argente J, eds. Human growth: basic and clinical aspects. Amsterdam: Elsevier; 295-306.
22. Zeitler P, Argente J, Chowen-Breed JA, Clifton CK, Steiner RA. 1990 Growth hormone-releasing hormone messenger ribonucleic acid in the hypothalamus of the adult male rat is increased by testosterone. Endocrinology. 127:1362-1368.
23. Degli Uberti ECD, Ambrosio MR, Cella SG, et al. 1997 Defective hypothalamic growth hormone (GH)-releasing hormone activity may contribute to declining GH secretion with age in man. J Clin Endocrinol Metab. 82:2885-2888.
24. Bando H, Zhang C, Takada T, Yamasaki R, Saito S. 1991 Impaired secretion of growth-hormone releasing hormone and IGF-I in elderly men. Acta Endocrinol (Copenh). 124:31-36.
25. De Gennaro Colonna V, Zoli M, Cocchgi D, et al. 1989 Reduced growth hormone releasing factor (GHRF)-like immunoreactivity and GHRF gene expression in the hypothalamus of aged rats. Peptides. 10:705-708.
26. De Leo VC, Lanzetta D, D'Antona D, Danero S. 1993 Growth hormone secretion in premenopausal women before and after ovariectomy: effect of hormone replacement. Fertil Steril. 60:268-271.
27. Aglio ED, Valenti G, Hoffman AR, Zuccarelli A, Passeri M, Ceda GP. 1993 Lack of effect of transdermal estrogen on growth hormone-insulin-like growth factor axis. Horm Metab Res. 26:211-212.
28. Tannenbaum GS, Guyda HJ, Posner BI. 1983 Insulin like growth factors: a role in growth hormone negative feedback and body weight regulation via brain. Science. 220:77-79.
29. Yamashita S, Melmed S. 1986 Insulin-like growth factor I action on rat anterior pituitary cells: suppression of growth hormone secretion and messenger ribonucleic acid levels. Endocrinology. 118:176-182.
30. Uchiyama T, Kaji H, Abe H, Chihara K. 1994 Negative regulation of hypothalamic growth hormone releasing factor messenger ribonucleic acid growth hormone and insulin-like growth factor I. Neuroendocrinology. 59:441-450.
31. Gil-Ad I, Weizman A, Silbergeld A, et al. 1996 Differential effect of insulin-like growth factor-I and growth hormone on hypothalamic regulation of growth hormone secretion in the rat. J Endocrinol Invest. 19:542-547.
32. Chapman IM, Hatman ML, Pezzoli SS, et al. 1997 Effect of aging on the sensitivity of growth hormone secretion to insulin-like growth factor-I negative feedback. J Clin Endocrinol Metab. 82:2996-3004.
33. Rosenfield RL, Furlanetto R. 1985 Physiologic testosterone or estradiol induction of puberty increase plasma somatomedin-C. J Pediatr. 107:415-417.
34. Harris DA, Van Vliet G, Egli CA, et al. 1985 Somatomedin-C in normal puberty and in true precocious puberty before and after treatment with a potent luteinizing-hormone releasing hormone agonist. J Clin Endocrinol Metab. 61:152-159.
35. Wilson ME, Gordon TP, Tanner JM. 1993 Constant low dose oestradiol replacement accelerates skeletal maturation and growth in ovariectomized adolescent monkeys. J Endocrinol. 137:519-527.
36. Wilson ME. 1997 Administration of IGF-I affects the GH axis and adolescent growth in normal monkeys. J Endocrinol. 153:327-335.
37. Gabrielsson BG, Cannignac DF, Flavell DM, Robinson IC. 1995 Steroid regulation of growth hormone (GH) receptor and GH-binding protein messenger ribonucleic acids in the rat. Endocrinology. 136:209-217.
38. Martin JL, Baxter RC. 1992 Insulin-like growth factor binding protein-3: biochemistry and physiology. Growth Regul. 75:30-36.
39. Gargosky SE, Tapanainen P, Rosenfeld RG. 1994 Administration of growth hormone (GH) but not insulin-like growth factor-I (IGF-I), by continuous infusion can induce the formation of the 150 kilodalton IGF-binding protein-3 complex in GH-deficient rats. Endocrinology. 134:2267-2276.
40. Kanety H, Karasik A, Klinger B, Sibergeld A, Laron A. 1993 Long-term treatment of Laron type dwarfs with insulin-like growth factor-I increases serum insulin-like growth factor binding protein-3 in the absence of growth hormone activity. Acta Endocrinol (Copenh). 128:144-149.
41. Gargosky SE, Wilson KF, Fielder PJ, et al. 1993 The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in serum of growth hormone deficient patients: effects of IGF-I therapy on IGFBP-3. J Clin Endocrinol Metab. 77:1683-1689.
42. Gosteli-Peter M, Winterhalter KH, Scmid C, Froesch ER, Zapf J. 1994 Expression and regulation of insulin-like growth factor-I and IGF-binding protein messenger ribonucleic acid levels in tissues of hypophysectomized rats infused with IGF-I and growth hormone. Endocrinology. 134:1329-1339.
43. Klein NA, Battaglia DE, Miller PB, Soules MR. 1996 Circulating levels of growth hormone, insulin like growth factor-I and growth hromone binding protein in normal women of advanced reproductive age. Clin Endocrinol (Oxf). 44:285-292.
44. Cuttler L, van Vliet G, Conte FA, Kaplan SL, Grumbach MM. 1985 Somatomedin-C levels in children and adolescents with gonadal dysgenesis: differences from age matched normal females and effect of chronic estrogen replacement therapy. J Clin Endocrinol Metab. 60:1087-1092.
45. Jernstrom H, Olsson H. 1994 Suppression of plasma insulin-like growth factor-I levels in healthy, nulliparous young women using low dose oral contraceptives. Gynecol Obstet Invest. 38:261-265.
46. Helle SI, Omsjo IH, Hughes SCC, et al. 1996 Effects of oral and transdermal oestrogen replacement therapy on plasma levels of insulin-like growth factors and IGF binding proteins 1 and 3: a cross-over study. Clin Endocrinol (Oxf). 45:727-732.
47. Lieberman SA, Mitchell AM, Marcus R, Hintz RL, Hoffman AR. 1994 The insulin-like growth factor I generation test: resistance to growth hormone with aging and estrogen replacement. Horm Metab Res. 26:229-233.
48. Wilson ME, Gordon TP, Rudman CG, Tanner JM. 1988 Effects of a natural vs. artificial environment on the tempo of maturation in female rhesus monkeys. Endocrinology. 123:2653-2661.
49. Wilson ME. 1995 IGF-I administration advances the decrease in hypersensitivity to oestradiol negative feedback inhibition of serum LH in adolescent female rhesus monkeys. J Endocrinol 145:121-130.
50. Osterud EL, Lackey SL, Wilson ME. 1986 Estradiol increases somatomedin-C concentrations in adolescent rhesus monkeys (Macaca mulatta). Am J Primatol. 11:53-62.
51. Xiao E, Xia L, Shanen D, Khabele D, Ferin M. 1994 Stimulatory effects of interleukin-induced activation of the hypothalmo-pituitary-adrenal axis on gonadotropin secretion in ovariectomized monkeys replaced with estradiol. Endocrinology. 133:2093-2098.
52. Lemmey AB, Glassford J, Flick-Smith HC, Holly JM, Pell JM. 1997 Differential regulation of tissue insulin-like growth factor-binding protein (IGFBP) -3, IGF-I, and IGF type 1 receptor mRNA levels, and serum IGF-I and IGFBP concentrations by growth hormone and IGF-I. J Endocrinol. 154:319-328.
53. Lillafuerte BC, Zhang WN, Phillips LS. 1996 Insulin and IGF-I regulate hepatic IGFBP-3 by different mechanisms. Mol Endocrinol. 10:622-630.
54. Bichell DP, Kikuchi K, Rotwein P. 1992 Growth hormone rapidly activates insulin-like growth factor 1 gene transcription in vivo. Mol Endocrinol. 6:1899-1908.
55. Hernandez ER. 1995 Regulation of genes for insulin-like growth factor (IGF) I and II and their receptors by steroids and gonadotropins in the ovary. J Steroid Biochem Mol Biol. 53:219-221.
56. Attie KM, Ramirez NR, Conte FA, Kaplan SL, Grumbach MM. 1990 The pubertal growth spurt in eight patients with true precocious puberty and growth hormone deficiency: evidence for a direct role of sex steroids. J Clin Endocrinol Metab. 71:975-983.
57. Xu X, Bennett SA, Ingram RL, Sonntag WE. 1996 Decreases in growth hormome receptor signal transduction contribute to the decline in insulin-like growth factor 1 gene expression with age. Endocrinology. 136:4551-4557.
58. Corpas E, Harman SM, Pineyro MA, Roberson R, Blackman MR. 1993 Continuous subcutaneous infusion of growth hormone (GH) releasing hormone 1-44 for 14 days increase GH and insulin-like growth factor-I levels in old men. J Clin Endocrinol Metab. 76:134-138.
59. Adesanya OO, Zhou J, Bondy CA. 1996 Sex steroid regulation of insulin-like growth factor system gene expression and proliferation in primate myometrium. J Clin Endocrinol Metab. 81:1967-1974.
60. Zapf J. 1995 Physiological role for the insulin-like binding proteins. Eur J Endocrinol. 132:645-654.
61. Suikkari AM, Koivisto VA, Koistinen R, Seppala M, Yki-Jarvinen H. 1989 Dose-response characteristics for suppression of low molecular weight plasma insulin-like growth factor-binding protein by insulin. J Clin Endocrinol Metab. 68:135-140.
62. Rutanen EM, Karkkainen T, Stenman UH, Yki-Jarvinen H. 1997 Aging is associated with decreased suppression of insulin-like growth factor binding protein-1 by insulin. J Clin Endocrinol Metab. 77:1152-1155.
63. Martikainen H, Koistinen R, Seppala M. 1992 The effect of estrogen level on glucose-induced changes in serum insulin-like growth factor binding protein-1 concentration. Fertil Steril. 58:543-546.
64. Brussaard HE, Gevers-Leuven JA, Frolich M, Kluft C, Krans HM. 1997 Short-term oestrogen repalcement therapy improves insulin resistance, lipids and fibrinoloysis in postmenopausal women with NIDDM. Diabetologia. 40:843-849.
65. Rosenthal SM, Kaplan SL, Grumbach MM. 1989 Short term continuous intravenous infusion of growth hormone (GH) inhibits GH-releasing hormone-induced GH secretion: a time dependent effect. J Clin Endocrinol Metab. 68:1101-1105.
66. Sugihara H, Minami S, Wakabayashi I. 1989 Post-somatostatin rebound of GH secretion is dependent on growth-hormone releasing factor in unrestrained female rats. J Endocrinol. 122:583-591.
67. Rogol AD, Evans WS, Vance ML, et al. 1987 Circulating growth hormone concentrations in response to the pulsatile administration of growth hormone releasing hormone. In: Crowley WF, Hofler JG, eds. The episodic secretion of hormones. New York: Wiley and Sons; 341-358.
68. Ge F, Tsagarakis S, Rees LH, Besser GM, Grossman A. 1988 Relationship between growth hormone releasing hormone and somatostatin in the rat: effects of age and sex on content and in vitro release from hypothalamic explants. J Endocrinol. 123:53-58.
69. Spik K, Sonntag WE. 1989 Increased pituitary response to somatostatin in aging male rats: relationship to somatostatin receptor number and affinity. Neuroendocrinology. 50:489-494.
70. Korbonits M, Little JA, Camach-Hubner C, Trainer PJ, Besser GM, Grossman AB. 1996 Insulin-like growth factor-I and -II in combination inhibit the release of growth hormone releasing hormone from the rats hypothalamus in vitro. Growth Regul. 6:110-120.
71. Becker K, Stegenga S, Conway S. 1995 Role of insulin like growth factor I in regulating growth hormone release and feedback in the male rat. Neuroendocrinology. 61:573-583.
72. Ghigo MC, Torsello A, Grilli R, et al. 1997 Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels. I. A study on ad libitum and starved adult male rats. J Endocrinol Invest. 20:144-150.
73. Melmed S, Yamashita S, Yamasaki H, et al. 1996 IGF-I signalling: lesions from the somatotroph. Recent Prog Horm Res. 51:189-215.
74. Lanzi R, Tannenbaum GS. 1992 Time course and mechanism of growth hormone's negative feedback on its own spontaneous release. Endocrinology. 130:780-782.
75. Herbison AE, Theodosis DT. 1996 Absence of estrogen receptor immunoreactivity in somatostatin (SRIF) neurons of the periventricular nucleus but sexually dimorphic colocalization of estrogen receptor and SRIF immunoreactivities in neurons of the bed nucleus of the stria terminalis. Endocrinology. 132:1707-1714.
76. Chowen-Breed JA, Steiner RA, Clifton DK. 1989 Sexual dimorphism and testosterone-dependent regulation of somatostatin gene expression in the periventricular nucleus of the rat brain. Endocrinology. 125:357-362.